Mobious Genomics Allowed Milestone US Sequencing Patents
Exeter, England. Mobious Genomics Ltd., the UK based bionanotechnology company, announced that it has received formal notice of allowance from the United States Patent Office for broad technology defining patents covering real-time polynucleotide sequencing. The patents outline the application of cellular replication systems to achieve commercially viable ultra high speed sequencing technology.
Relating to methods and devices for real-time monitoring of cellular replication processes in order to achieve ultra high throughput Genomic analysis as well as robust "regenerative" capabilities, the patents cover core elements of Mobious's platform technology. The patents are held my Mobious's patent holding company, Medical Biosystems Ltd.
Most read news
Organizations
Other news from the department research and development
![Newsletter](https://img.chemie.de/assets/awportal/images/newsletter.png)
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.